🇺🇸 FDA
Patent

US 12427121

Enhanced delivery epinephrine compositions

granted A61KA61K31/075A61K31/137

Quick answer

US patent 12427121 (Enhanced delivery epinephrine compositions) held by Aquestive Therapeutics, Inc. expires Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Aquestive Therapeutics, Inc.
Grant date
Tue Sep 30 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
32
CPC classes
A61K, A61K31/075, A61K31/137, A61K36/61, A61K45/06